Ting Liu, James F. Sanchez, Yi-Ming Chiang, Berl R. Oakley, and Clay C. C. Wang
Table of Contents
Supplemental Methods S2 Supplemental Discussion on 1 and products in equilibrium S5 Table S1 . Products from NR-PKSs used in this study S6 Table S2 . A. nidulans strains used in this study S7 Table S3 . Primers used in this study S9 Table S4 . 1 H and 13 C NMR data for compounds 5 and 4 S11 Figure S1 . Gene deletion and domain swap strategies in this study S12 Figure S2 . UV-Vis and ESIMS spectra (negative mode) of compounds 5 and 4. S13 Figure S3 . HMBC correlations of compounds 5 and 4. S14 Supplemental References S15 Figure S4 . 1 H NMR spectrum of compound 5 S16 Figure S5 . 13 C NMR spectrum of compound 5 S17 Figure S6 . 1 H NMR spectrum of compound 4 S18 Figure S7 . 13 C NMR spectrum of compound 4 S19
Supplemental Methods
Fungal strains and molecular genetic manipulations A. nidulans strains used in this study are listed in Table S1 . All primers used in this study are listed in Table S2 .
Gene deletions were carried out in LO4852 for AN3386 and in LO2026 for the other 8 PKS genes by replacing the target gene with the selection marker, Aspergillus fumigatus pyroA (AfpyroA) gene ( Figure S1A ). Chimeric PKS genes were constructed after gene deletion.
For SAT domain swaps as shown in Figure S1B , the afoE SAT plus a 120bp upstream promoter region was replaced with a DNA cassette containing 1) a selection marker
[Aspergillus fumigatus pyrG (AfpyrG) or riboB (AfriboB) gene] followed by 2) a 401bp A.
nidulans alcA promoter [alcA(p)] followed by 3) the SAT portion of a donor gene starting from the start codon and ending at the selected junction site, so that the chimeric gene was under the control of the alcA promoter. This strategy was also applied to the extended domain swap between AN3386 and afoE except that the donating portion of AN3386 and receiving region of afoE were extended.
Two ~1000bp-fragments upstream and downstream of each targeted DNA region were amplified from A. nidulans genomic DNA by PCR and fused together with the replacement cassette by fusion PCR. 1 Protoplast production and transformation were carried out as described. 1 Three to five transformants for each genotype were analyzed by diagnostic PCR with three primer sets. When the external primers in the first round of PCR were used, the difference in the sizes of targeted DNA region before and after replacement allowed the determination of correct gene replacement. When one of the external primers and the primer located inside the cassette were used, the correct mutant gave the PCR product of the expected size, otherwise no product was present. 
Fermentation and LC-MS analysis

Isolation and identification of secondary metabolites
For structure elucidation of compound 5 which was mainly produced in mycelium, 4.0x10 The NMR data for compound 4 were also highly similar to that of established compound 2.
The mass difference and the 13 C NMR resonance at 176.6 were indicative of a carboxylic acid functionality. 2D NMR experiments established the C18 position of the carboxylic acid and fully corroborated our proposed structure.
Compound Identification
Nuclear magnetic resonance (NMR) spectra of 1 and 4 were respectively collected on a
Varian Mercury Plus 400 spectrometer and a Varian 400-MR 2-Channel NMR Spectrometer.
Compound 1: brown solid; For UV and ESI-MS data, see Figure S2 ; For 1 H and 13 C NMR data, see Table S3 .
Compound 4: yellow solid; For UV and ESI-MS data, see Figure S2 ; For 1 H and 13 C NMR data, see Table S3 .
Supplemental Discussion on 1 and products in equilibrium
Compound 1 in the current text was the product of a genetic knock out in an earlier project. 12 The minor products as marked with an asterisk in the current text were isolated and characterized by NMR, using acetone-d 6 . We had found that their spectra matched that of the major product. Given this result and the chemical structure of the major product, we reasoned that the minor products were cyclic hemiacetals in equilibrium with the major product. The identity of the solvent may affect the equilibrium. We have now performed HRMS analysis of compound 1 and the minor products. In positive mode the measured masses for 1a, and 1b were 299.1639, and 299.1658, respectively, corresponding to metabolites with a molecular formula of C 19 As Figure 1 in the main text shows, there is no clear sign of the hemiacetal forms of 2 and 4. The equilibrium may favor the hemiacetals less than with 1, but it cannot be discounted that equilibrium was not reached before the samples underwent the LC/MS experiment. Figure S4 . 1 H NMR of compound 5 S16 Figure S5 . 13 C NMR of compound 5 S17 Figure S6 . 1 H NMR of compound 4 S18 Figure S7 . 13 C NMR of compound 4 S19
